Company Overview and News
Indian state-owned firms mandated to acquire overseas lithium and cobalt assets - A rough deadline of March 2019.
SIE PIO CLA PANRF CCZ PAN HAV MCR KBGCF CTM AXE IGO VIC BAR AOU HIG PCRCF PLM.RT TAKRF SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS DLE HBNRF MEI PIONF BPLNF CZI AMSLF HMI POS AUZ RNX GME FQVLF AQR PTNUF PCRFY FT HNLMF ORR CDNMD CDNMF IIDDY AEOMF USCFF KATFF BBBMF MLXEF OZMLF PLM CNJ AZRMF TSLA HLPCF BPL BHP OZL ARV
Six cobalt junior developers can each produce ~5,000 tonnes pa of cobalt by 2021/22. These companies each have the potential to be worth ~AUD 3b if cobalt prices remain strong.
CLA CCZ HAV GLCNF ECSIF CZI AMSLF BPLNF POS HIG AUZ RNX RNKLF GME AQR FT PSDNF AYR AEOMF KATFF RNX.WT FTMDF KAT CNJ BPL HLPCF CSSQF
Cobalt miner news - South Korea's LG Chem to set up battery material JVs with China's Zhejiang Huayou Cobalt.
SIE PIO PANRF CCZ PAN HAV MCR KBGCF FCX IGO VIC BAR AOU HIG PCRCF PLM.RT TAKRF SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR SHERF CDU RGARF CHK MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS DLE HBNRF MEI PIONF CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT HNLMF ORR CDNMD CDNMF IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM CNJ AZRMF HLPCF BPL BHP OZL ARV
This article first appeared on Trend Investing on February 16, therefore all data is as of that date.
SIE PANRF NSRPF PAN HAV KBGCF MCR IGO VIC BAR AOU HIG PLM.RT TAKRF SNNAF FQM MCRZF MLX PSDNF POM CHK RNX.WT MCRZY FTMDF KAT AAUKF CSSQF CZN PGM GBLEF AZS HBNRF MEI CZI AMSLF BPLNF HMI POS AUZ RNX RNKLF GME FQVLF AQR PTNUF FT HNLMF NVO ORR AAL IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM CBLLF CNJ AZRMF BPL HLPCF BHP OZL NGLOY ARV
Cobalt spot price news - Spot prices rise 18.7% in the past month as inventory falls. The cobalt spot price is now over USD 40/lb, and approaching USD 100,000/tonne.
SIE PIO PANRF HAV PAN KBGCF MCR FCX ECSIF IGO VIC BAR AOU HIG PLM.RT TAKRF UMICF SNNAF FQM LGI MCRZF BXTMF MLX PSDNF POM CDU RGARF CHK VLKAF MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF HMI POS AUZ RNX GME AAPL FQVLF AQR MBL PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM S CNJ AZRMF HLPCF BHP OZL ARV
The Sconi resource estimate has 54,500 tonnes of contained cobalt with exploration upside. The Sconi project has recently secured 100% cobalt and nickel off-take.
FT PSDNF HAV ECSIF AEOMF CZI AMSLF KATFF POS HIG AUZ RNX FTMDF KAT GME CNJ HLPCF CSSQF AQR GMRSF
2018-06-24 - Asif
History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
Silicon Investor Message Boards
This table lists all message boards related to TSX:FT / Fortune Mnrl J on message board site Silicon Investor.